Bicara Therapeutics Inc.(BCAX)
$10.11-0.42 (-3.99%)
BCAX
Bicara Therapeutics Inc. earnings date
$10.11
At close:-0.42 (-3.99%)
Want to see BCAX full AI Analyst Report?
Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Report
93 Followers
BCAX Q2 2026 EPS Results
- Actual EPS
- -$0.82
- Consensus EPS
- -$0.82
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$0.50
BCAX Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- Before Open
- Conference Call
- Tuesday, August 11, 2026
BCAX Upcoming Earnings
Bicara Therapeutics Inc.'s next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
BCAX Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
BCAX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -0.99- | -0.93 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.82-1.04 | -0.67 | -55.22% (-0.37) | |
| Aug 11, 2026 | 2026 (Q2) | -0.82-0.82 | -0.5 | -64.00% (-0.32) | |
| May 11, 2026 | 2026 (Q1) | -0.65-0.93 | -0.68 | -36.76% (-0.25) | |
| Mar 30, 2026 | 2025 (Q4) | -0.67-0.68 | -0.39 | -74.36% (-0.29) | |
| Nov 18, 2025 | 2025 (Q3) | -0.54-0.67 | -1.6 | 58.13% (+0.93) | |
| Aug 12, 2025 | 2025 (Q2) | -0.55-0.50 | -0.45 | -11.11% (-0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.41-0.68 | ― | ― | |
| Mar 27, 2025 | 2024 (Q4) | -0.33-0.39 | ― | ― | |
| Nov 12, 2024 | 2024 (Q3) | -0.41-1.60 | -0.42 | -280.95% (-1.18) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
